| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
N6-Furfuryl-2'-C-methyladenosine manufacturers
|
| | N6-Furfuryl-2'-C-methyladenosine Basic information |
| Product Name: | N6-Furfuryl-2'-C-methyladenosine | | Synonyms: | N6-Furfuryl-2'-C-methyladenosine;N6-(2-furanylmethyl)-9H-(3-C-methyl-β-D-ribofuranosyl)adenine;N6-Furfuryl-2’-C-methyladenosine;(2R,3S,4R,5R)-5-(6-((furan-2-ylmethyl)amino)-9H-purin-9-yl)-2-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol;Adenosine, N-(2-furanylmethyl)-3'-C-methyl- | | CAS: | 1042976-44-2 | | MF: | C16H19N5O5 | | MW: | 361.35 | | EINECS: | | | Product Categories: | | | Mol File: | 1042976-44-2.mol |  |
| | N6-Furfuryl-2'-C-methyladenosine Chemical Properties |
| Boiling point | 666.0±65.0 °C(Predicted) | | density | 1.68±0.1 g/cm3(Predicted) | | pka | 13.14±0.70(Predicted) |
| | N6-Furfuryl-2'-C-methyladenosine Usage And Synthesis |
| Uses | N6-Furfuryl-2’-C-methyladenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | N6-Furfuryl-2'-C-methyladenosine Preparation Products And Raw materials |
|